BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27399585)

  • 1. Clinical presentation and risk factors of serious infections in children with Down syndrome treated for acute lymphoblastic leukemia.
    Ceppi F; Stephens D; den Hollander BS; Krueger J; Whitlock J; Sung L; Hitzler J
    Pediatr Blood Cancer; 2016 Nov; 63(11):1949-53. PubMed ID: 27399585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for infection-related outcomes during induction therapy for childhood acute lymphoblastic leukemia.
    Afzal S; Ethier MC; Dupuis LL; Tang L; Punnett AS; Richardson SE; Allen U; Abla O; Sung L
    Pediatr Infect Dis J; 2009 Dec; 28(12):1064-8. PubMed ID: 19773675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
    Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
    Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.
    Li MJ; Chang HH; Yang YL; Lu MY; Shao PL; Fu CM; Chou AK; Liu YL; Lin KH; Huang LM; Lin DT; Jou ST
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.
    Rabin KR; Smith J; Kozinetz CA
    Pediatr Blood Cancer; 2012 Apr; 58(4):633-5. PubMed ID: 22106003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma--a rationale for tailored supportive care.
    Lex C; Körholz D; Kohlmüller B; Bönig H; Willers R; Kramm CM; Göbel U
    Support Care Cancer; 2001 Oct; 9(7):514-21. PubMed ID: 11680831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections in acute lymphoblastic leukaemia.
    Chong CY; Tan AM; Lou J
    Ann Acad Med Singap; 1998 Jul; 27(4):491-5. PubMed ID: 9791652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
    Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supportive care utilization and treatment toxicity in children with Down syndrome and acute lymphoid leukaemia at free-standing paediatric hospitals in the United States.
    Salazar EG; Li Y; Fisher BT; Rheingold SR; Fitzgerald J; Seif AE; Huang YS; Bagatell R; Aplenc R
    Br J Haematol; 2016 Aug; 174(4):591-9. PubMed ID: 27161549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
    J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
    Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
    Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious profile in children with ALL during chemotherapy: A report of study group for infections.
    Zawitkowska J; Drabko K; Szmydki-Baran A; Zaucha-Prażmo A; Lejman M; Czyżewski K; Zalas-Więcek P; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Kulicka E; Semczuk K; Hutnik Ł; Chełmecka-Wiktorczyk L; Klepacka J; Frączkiewicz J; Salamonowicz M; Tomaszewska R; Zając-Spychała O; Irga-Jaworska N; Bień E; Płonowski M; Bartnik M; Ociepa T; Pierlejewski F; Woszczyk M; Gamrot-Pyka Z; Małas Z; Urbanek-Dądela A; Stolpa W; Musiał J; Styczyński J
    J Infect Chemother; 2019 Oct; 25(10):774-779. PubMed ID: 31101529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
    Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
    Lehrnbecher T; Varwig D; Kaiser J; Reinhardt D; Klingebiel T; Creutzig U
    Leukemia; 2004 Jan; 18(1):72-7. PubMed ID: 14586478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
    Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
    Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
    Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reduction of therapy on infectious complications in childhood acute lymphoblastic leukemia.
    Graubner UB; Porzig S; Jorch N; Kolb R; Wessalowski R; Escherich G; Janka GE
    Pediatr Blood Cancer; 2008 Feb; 50(2):259-63. PubMed ID: 17635005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections occurring during the courses of anticancer chemotherapy in children with ALL: a retrospective analysis of 59 patients.
    Rahiala J; Perkkiö M; Riikonen P
    Pediatr Hematol Oncol; 1998; 15(2):165-74. PubMed ID: 9592843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.